Hepatic Oncology
Volume 7, 2020 - Issue 2
Editorial
HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
Devis Pascut1 Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149Trieste, ItalyCorrespondence[email protected]
https://orcid.org/0000-0003-0583-1973View further author information
https://orcid.org/0000-0003-0583-1973View further author information, & Claudio Tiribelli1 Fondazione Italiana Fegato – ONLUS, Liver Research Center, AREA Science Park, ss14, Km163.5, Basovizza, 34149Trieste, Italyhttps://orcid.org/0000-0001-6596-7595View further author information
https://orcid.org/0000-0001-6596-7595View further author information